Navigation Links
Christopher Bowe Joins Scrip as US Healthcare Analyst
Date:9/27/2010

Christopher Bowe Joins Scrip as US Healthcare Analyst -- NEW YORK, September 27, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Publishing & Information Services, Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Personnel Announcements Click to view news release full screen  

Christopher Bowe Joins Scrip as US Healthcare Analyst

 

NEW YORK, September 27, 2010 /PRNewswire/ -- Scrip, the market-leading international pharmaceutical and biotech information provider, has appointed Christopher Bowe to the post of US Healthcare Analyst as part of its expansion of an analyst team to serve subscribers.

With his appointment, Bowe will help expand the high-value original and topical analysis of pharmaceutical and healthcare industries, policy and regulation, as well as engage and serve customers through Scrip's tailored project research advisory services of Ask the Analyst. He will be available to media to comment on trends, news and insights derived from original Scrip analysis. His work will cross a diverse constituency ranging from industry, to the financial analyst community, to researchers to communications and consultancy groups.

Christopher joins Scrip and its highly-acclaimed, award-winning news, analysis and data services with more than two decades of experience working in and commentating on the global pharma and biotech industry.

"Christopher has a wealth of industry knowledge and experience and we are delighted that he has joined the analyst team," says Dr Philip Smith, Research Director at Informa, publishers of Scrip. "Our users will benefit from his in-depth knowledge of the US healthcare market gained from extensive experience in the senior journalist roles and more recently, as a senior advisor to top management at a major US pharmaceutical company."

Scrip Intelligence, Clinica MedTech News and the Regulatory Affairs Pharma and Medtech titles will all feature Christopher's content ranging across the North American pharma and medtech sectors and including analysis of current issues in business strategy, policy, regulatory affairs, R&D, technology and company intelligence.

Bowe's appointment also strengthens Scrip's commitment to client research support, which is available through the Ask the Analyst services.

"It is an honour to join the team at Scrip," says Bowe, who will be based in New York, USA. "I look forward to engaging subscribers and providing analysis that leaders and decisionmakers want and need in order to gain competitive insights. The world of healthcare is changing so quickly and original analysis is of high importance.

"I am also very excited about the power of analysis and data through access to the extensive intelligence within the Scrip group," he says.

"Christopher's arrival is an exciting milestone for Scrip's business intelligence services, particularly in the US," continues Dr Smith. "We are setting a new standard in information provision with the recent launch of our cutting-edge SCRIP Intelligence news, analysis and data and Ask the Analyst services. Christopher's experience and knowledge of the industry will help to ensure that the Scrip range of titles remains second-to-none in serving the intelligence needs of those working in and with the global pharma and biotech sectors."

In his most recent role, Christopher served as Counselor, Strategic Affairs for Schering-Plough working directly with CEO Fred Hassan as well as his senior management team. Prior to that, he served as US Healthcare Correspondent and Chicago Correspondent for the Financial Times and as Chicago Correspondent for Dow Jones Newswires.

For more information on Scrip's pharma and medtech intelligence services, please visit the following websites: http://www.scripintelligence.com http://www.clinica.co.uk http://www.rajpharma.com http://www.rajdevices.com
'/>"/>

SOURCE Informa
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
2. Ameristar National Charity Golf Classic Raises More Than $1.1 Million for Buoniconti Fund to Cure Paralysis and Christopher & Dana Reeve Foundation
3. Christopher and Dana Reeve Foundation Response to FDA Clearance of Gerons Clinical Trial
4. VITAS Innovative Hospice Care(R) Names Christopher Rieder Senior Vice President and Chief Information Officer
5. Fina Technologies Names Spotfire Founder Christopher Ahlberg to Board of Directors
6. Christopher Brennan Joins PharmaNet Development Group as General Counsel
7. WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Companys Scientific Advisory Board
8. John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technologys Potential to Help Millions of Patients
9. Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development
10. GM Exec Joins Bio-Reaction Industries Board of Directors
11. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... McLean, VA (PRWEB) , ... February 06, 2016 , ... ... enrichment session, cost-free, for middle and high school teachers on Wednesday February 10, 2016. ... be held at the Smithsonian-Mason School of Conservation, located at 1500 Remount Road in ...
(Date:2/5/2016)... 5, 2016  In the pharmaceutical industry the medical ... of launch activities including the identification and engagement of ... is especially high in the oncology therapeutic area where ... and the Role of Medical Affairs in Oncology Launch ... oncology therapies find better ways to utilize medical affairs ...
(Date:2/5/2016)... Australian-US drug discovery and development company, Novogen Limited ... a new Chairman, Mr John O,Connor , and new ... James Garner , has also been formally appointed ... CEO, Mr Iain Ross , will resume his role ... James Garner , has also been formally appointed to the ...
(Date:2/4/2016)... 4, 2016  Sangamo BioSciences, Inc. (NASDAQ: SGMO ... that Edward Lanphier , Sangamo,s president and chief ... of Sangamo,s ZFP Therapeutic ® development programs and ... pm ET on Thursday, February 11, 2016, at the ... The conference is being held in New ...
Breaking Biology Technology:
(Date:2/3/2016)... 2016 Vigilant Solutions announces today that the ... Missouri solved two recent hit-and-run cases ... from Vigilant Solutions. Brian Wenberg explains, ... victim was walking out of a convenience store and witnessed an elderly male ... vehicle, striking his vehicle and leaving the scene.  In ...
(Date:2/2/2016)... , Feb. 2, 2016 This ... the bioinformatic market by reviewing the recent advances ... tools that drive the field forward. Includes forecast ... Identify the challenges and opportunities that exist ... and software solution developers, as well as IT ...
(Date:2/2/2016)... Va. , Feb. 2, 2016   ... award from the U.S. Army Research Office and ... the range and sensitivity of the company,s ... Past Accounting Mission and, more generally, defense-related DNA ... DNA phenotyping capabilities (predicting appearance and ancestry from ...
Breaking Biology News(10 mins):